Joint Formulary & PAD

Atropine sulfate - Hypersalivation in adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Eye drops
  • Sub-lingual drops
Associated Icons :
Guidelines
Off Label
SPC
Restrictions / Comments :
Important

Off-label use. 1% Eye drops used sublingually. Primary Care may prescribe on request from the specialist team.

 

Status 2

Blue
Formulations :
  • Eye drops (unit dose)
  • Sub-lingual drops
Associated Icons :
Guidelines
Off Label
SPC
Restrictions / Comments :
Important
1% Minims eye drops used sublingually. Each unit dose can continue to be used for 24 hours after opening (multiple doses). One Minims unit per day. Off-label use. Primary Care may prescribe on request from the specialist team.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Atropine sulfate
Indication :
Hypersalivation in adults
Group Name :
Keywords :
excessive saliva, hypersialosis, drooling, sialorrhoea
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.